The global CAR T-cell therapy market is witnessing rapid growth, driven by increasing prevalence of cancer and favorable regulatory approvals. Leading players in the market are participating in innovation to expand their product portfolio and cater the growing demand for effective cancer treatments. Furthermore, advancements in CAR T-cell therapy